Eyenovia Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EYENOVIA, and what generic alternatives to EYENOVIA drugs are available?
EYENOVIA has two approved drugs.
There are five US patents protecting EYENOVIA drugs.
There are sixty-four patent family members on EYENOVIA drugs in twenty countries and three supplementary protection certificates in three countries.
Summary for Eyenovia
| International Patents: | 64 |
| US Patents: | 5 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Eyenovia
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eyenovia | MYDCOMBI | phenylephrine hydrochloride; tropicamide | SPRAY, METERED;OPHTHALMIC | 215352-001 | May 5, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Eyenovia | CLOBETASOL PROPIONATE | clobetasol propionate | SUSPENSION/DROPS;OPHTHALMIC | 218158-001 | Mar 4, 2024 | RX | Yes | Yes | 11,376,262 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Eyenovia | MYDCOMBI | phenylephrine hydrochloride; tropicamide | SPRAY, METERED;OPHTHALMIC | 215352-001 | May 5, 2023 | RX | Yes | Yes | 11,398,306 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Eyenovia | CLOBETASOL PROPIONATE | clobetasol propionate | SUSPENSION/DROPS;OPHTHALMIC | 218158-001 | Mar 4, 2024 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Eyenovia | MYDCOMBI | phenylephrine hydrochloride; tropicamide | SPRAY, METERED;OPHTHALMIC | 215352-001 | May 5, 2023 | RX | Yes | Yes | 11,839,487 | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Eyenovia Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2018153667 | ⤷ Subscribe |
| Japan | 2013531044 | ⤷ Subscribe |
| Japan | 2016154868 | ⤷ Subscribe |
| Israel | 255452 | ⤷ Subscribe |
| Canada | 2985171 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Eyenovia Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1534313 | 92923 | Luxembourg | ⤷ Subscribe | PRODUCT NAME: UNE SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; FIRST REGISTRATION: 20150730 |
| 1534313 | 2015/071 | Ireland | ⤷ Subscribe | PRODUCT NAME: AN OCULAR IRRIGATION SOLUTION COMPRISING PHENYLEPHRINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND KETOROLAC OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/15/1018 20150728 |
| 1534313 | 15C0090 | France | ⤷ Subscribe | PRODUCT NAME: SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/15/1018 20150728 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
